Eye News and Research

Latest Eye News and Research

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

ZEISS adds INFRARED 800 to OPMI PENTERO 800 for reconstructive surgery

ZEISS is now adding INFRARED 800 to its OPMI PENTERO 800 surgical microscope for reconstructive surgery. The new enhancements are tailored to the requirements of breast reconstruction, lymph supermicrosurgery, and oral and maxillofacial surgery. Clinical specialists can benefit from the optimized package of ZEISS OPMI PENTERO 800 which provides intraoperative assessment of blood flow, higher magnification and effortless maneuverability required for complex reconstructive surgery.

4 Nov 2015

Good news for patients suffering from dry age-related macular degeneration

Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression of the blinding condition. Published in Investigative Ophthalmology & Visual Science, the findings indicate that treatments currently used for other conditions could also work for dry AMD.

3 Nov 2015

Study identifies potential new approaches to curing parasitic diseases

A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

3 Nov 2015

Experts call on U.S. and Mexican governments to reduce risk of Chagas disease

Chagas disease -- the third most common parasitic infection in the world -- affects approximately 7.5 million people, mostly in Latin America. To help reduce outbreaks of this disease in their countries, the United States and Mexican governments should implement a range of programs as well as fund research for the development of Chagas vaccines and treatments, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

3 Nov 2015

Healthy food can help low-income people better control their diabetes

To determine whether healthy food could help low-income people better control their diabetes, a pilot study by UC San Francisco and Feeding America tracked nearly 700 people at food banks in California, Texas and Ohio over two years.

3 Nov 2015

Discovery offers promising alternative to current therapies for AMD and ROP

A research team led by scientists at Beth Israel Deaconess Medical Center and the University of New Mexico School of Medicine has identified a small molecule that treats animal models of aged macular degeneration (AMD) and retinopathy of prematurity (ROP) by preventing the overgrowth of blood vessels that are characteristic of these two retinal diseases.

3 Nov 2015

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Charles Bonnet syndrome is the name we give to the visual hallucinations associated with eye disease. There are lots of different causes of visual hallucinations. Many different medical problems and medications can cause them, but, when the cause is eye disease, it's referred to as Charles Bonnet Syndrome after Charles Bonnet, who was a natural philosopher in the 18th century.

2 Nov 2015

Researchers discover two new structures in cornea of human eye

"It's not everyday that one newly discovers parts of the human body," says Roy S. Chuck, MD, PhD, Chairman Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine.

31 Oct 2015

Saint Louis University ophthalmologist offers tips to manage night vision issues

Owls and cats are at an advantage as the days get darker, but humans may notice their vision takes a hit during their evening commute home as daylight hours shrink.

31 Oct 2015

Lucimed offers Luminette light therapy glasses for people suffering from seasonally induced issues

For millions of people, the arrivalof fall and winter are unwelcome events. A change in seasons often brings a change in their physical and mental health, due to fewer hours of sunlight.

31 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

University of Leicester hosts sports event to raise awareness of Nystagmus

The University of Leicester will be hosting an event to introduce sports for people with reduced vision and to raise awareness of the eye condition Nystagmus on Sunday 1 November.

29 Oct 2015

New, simpler surgical intervention not better than old method for treatment of intestinal perforation

A new and simpler surgical method for the treatment of intestinal perforation is a poorer alternative for patients compared to the old method, researchers at the University of Oslo and Akershus University Hospital find. The study raises important questions about the testing of new surgical methods.

28 Oct 2015

Lund University researchers reveal how nerve cells learn and forget

Our brains not only contain learning mechanisms but also forgetting mechanisms that erase "unnecessary" learning. A research group at Lund University in Sweden has now been able to describe one of these mechanisms at the cellular level.

28 Oct 2015

Oxytocin treatment improves social, emotional and behavioral problems among young kids with autism

A five week treatment with the synthetic hormone oxytocin significantly improved social, emotional and behavioral issues among young children with autism, according to University of Sydney research published today in Molecular Psychiatry.

27 Oct 2015

NYSCF conference to focus on translational stem cell and neuroscience research

The New York Stem Cell Foundation 10th Annual Translational Stem Cell Research Conference convenes global leaders in translational stem cell and neuroscience research to present their latest work towards new treatments and cures for the most devastating diseases and injuries currently facing the world.

26 Oct 2015

Study shows surgery may not be a best option for AC joint dislocations

Acromio-clavicular joint dislocation is one of the most common shoulder injuries orthopedic surgeons treat. Severe dislocations are often treated with surgery, but patients who opt for non-surgical treatment typically experience fewer complications and return to work sooner, according to new research published today in the Journal of Orthopaedic Trauma.

23 Oct 2015

Warwick researchers win prestigious RCGP award for work on diabetes

Researchers from the University of Warwick have won a prestigious award for their work on diabetes. The paper, entitled Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study, was named Research Paper of the Year in the diabetes category, by the Royal College of General Practitioners (RCGP).

23 Oct 2015

3-D model of animal brain provides more complete picture of brain's connectivity

The animal brain is so complex, it would take a supercomputer and vast amounts of data to create a detailed 3-D model of the billions of neurons that power it.

23 Oct 2015